news Development of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR Learn More > 10 10月 2025 Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager Learn More > 4 9月 2025 Therapeutic Approaches to Hidden Hearing Loss: Celia Belline Featured on This Week in Hearing Learn More > 12 8月 2025 Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 6月 2025 Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 5月 2025 Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 2月 2025 Cilcare to exhibit at ARO 2025 and present at the PIHL Satellite Symposium Learn More > 4 2月 2025 Cilcare appoints Dr. Preethi Sundaram to its Board of Directors Learn More > 30 1月 2025 Cilcare appoints Dr. Bettina M. Cockroft as Chief Medical Officer Learn More > 17 1月 2025 « Previous ページ1 ページ2 ページ3 ページ4 … ページ27 Next »
Development of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR Learn More > 10 10月 2025
Therapeutic Approaches to Hidden Hearing Loss: Celia Belline Featured on This Week in Hearing Learn More > 12 8月 2025
Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 6月 2025
Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 5月 2025
Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 2月 2025
